PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Endocrine, metabolic & immune disorders drug targets

Volumn 10, Issue 4, 2010, Pages 367-372

  Kwon, Myung Ja ^a   Wang, Ruiqing ^b   Ma, Jian ^b   Sun, Zuoming ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ALLOTRANSPLANTATION; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOENZYMES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954507884     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871530311006040367     Document Type: Review

References (0)